Related Experiment Videos
Additional tests of interest to the dermatologist
1Department of Dermatology, University of Texas-Houston Medical School.
Dermatologic Clinics
|January 1, 1994
Summary
Carcinoid syndrome involves specific symptoms. Diagnosis typically relies on urinary 5-hydroxyindoleacetic acid (5-HIAA) tests, though more sensitive methods are emerging.
Area of Science:
- Endocrinology
- Oncology
- Clinical Diagnostics
Background:
- Carcinoid syndrome is a rare condition caused by neuroendocrine tumors.
- Clinical manifestations can be diverse and sometimes subtle.
- Accurate diagnosis is crucial for timely management.
Purpose of the Study:
- To review the clinical manifestations of carcinoid syndrome.
- To discuss diagnostic approaches for carcinoid syndrome.
- To highlight the role of urinary 5-HIAA and newer tests.
Main Methods:
- Literature review of carcinoid syndrome.
- Discussion of established diagnostic markers.
- Mention of advanced diagnostic technologies.
Main Results:
- Urinary 5-hydroxyindoleacetic acid (5-HIAA) is the standard biomarker.
- Emerging diagnostic tests offer increased sensitivity and specificity.
- Clinical presentation guides the diagnostic workup.
Conclusions:
- Carcinoid syndrome diagnosis requires understanding its varied symptoms.
- Urinary 5-HIAA remains a key diagnostic tool.
- Advancements in testing improve diagnostic accuracy for carcinoid syndrome.